Breast Cancer Risk-Reducing Medications

JAMA. 2020 Jul 21;324(3):310. doi: 10.1001/jama.2020.11784.

Authors

Danielle Graham¹, Maggie L DiNome¹, Patricia A Ganz²

Affiliations

¹ University of California, Los Angeles.
² UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California.

PMID: 32692388
DOI: 10.1001/jama.2020.11784

No abstract available

Publication types

Patient Education Handout

MeSH terms

Adult
Age Factors
Anastrozole / therapeutic use
Androstadienes / therapeutic use
Anticarcinogenic Agents / therapeutic use*
Aromatase Inhibitors / therapeutic use
Breast Neoplasms / prevention & control*
Female
Humans
Raloxifene Hydrochloride / therapeutic use
Risk Factors
Selective Estrogen Receptor Modulators / therapeutic use*
Tamoxifen / therapeutic use

Substances

Androstadienes
Anticarcinogenic Agents
Aromatase Inhibitors
Selective Estrogen Receptor Modulators
Tamoxifen
Anastrozole
Raloxifene Hydrochloride
exemestane